Last reviewed · How we verify

Lidocaine 2% Jelly

Hermann Eye Center · FDA-approved active Small molecule

Lidocaine blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials to produce local anesthesia.

Lidocaine blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials to produce local anesthesia. Used for Topical anesthesia of the eye and ocular surface, Anesthesia for ophthalmic procedures and examinations.

At a glance

Generic nameLidocaine 2% Jelly
Also known asLidocaine Jelly, Lidocaine gel
SponsorHermann Eye Center
Drug classLocal anesthetic
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesia/Ophthalmology
PhaseFDA-approved

Mechanism of action

Lidocaine is a local anesthetic that works by inhibiting sodium influx through voltage-gated sodium channels in nerve fibers. This prevents depolarization and the generation of action potentials, thereby blocking nerve conduction. The jelly formulation allows topical application for surface anesthesia of mucous membranes and tissues.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results